Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-009845

CVP, Chief Financial Officer sold 7,255 shares at $62.66 ($454,569)

  • CVP, Chief Financial Officer acquired 7,255 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ullem Scott B. · CVP, Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-10-31 Exercise or conversion : show line 1 in the form 10b5-1 +7,255 $36.75 $266,621 26,503 D
2023-10-31 Sale : show line 2 in the form 10b5-1 −7,255 $62.66 $454,569 19,248 D
Open-market sales · 7,255 sh · avg $62.66 · $454,569

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-10-31 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −7,255 $36.75 2024-05-10 7,255 43,525 D
Loading xslF345X05/doc4.xml…